
    
      Investigators hypothesize that using individual patient proliferation saturation index (PSI)
      to select radiotherapy fractionation (conventional fractionation or hyperfractionation) may
      improve the likelihood of a rapid response (defined as â‰¥ 32% reduction in volume at 4 weeks).
    
  